iSpecimen vs OneMedNet
ISPC and ONMD side by side, both in engineering, accounting, research, management, and related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ISPC and ONMD compare
OneMedNet is the larger company, worth 178 times as much as iSpecimen ($318M against $1.8M).
OneMedNet grew revenue faster over the last twelve months (217% versus −92.1% for iSpecimen).
OneMedNet keeps more of each dollar of sales as profit, with a net margin of −584% compared with −2449% at iSpecimen.
iSpecimen scores higher on the StockData Score (7 against 3 for OneMedNet), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ISPC | ONMD |
|---|---|---|
| Size and price | ||
| Market cap | $1.8M | $318M |
| Share price | $0.709 | $5.37 |
| Change, 1 year | −97.2% | −65.4% |
| Change, 5 years | −100.0% | −94.7% |
| Beta (5Y) | 0.61 | −0.24 |
| Employees | 53 | 23 |
| StockData Score | ||
| Total score | 7 (better) | 3 |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 4 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 3.8× (better) | 219× |
| P/B | 1.0× | – |
| FCF yield | – | −2.2% |
| Fair value | $0.985 | – |
| Margin of safety | 28.0% | – |
| Growth | ||
| Revenue growth (TTM) | −92.1% | 217% (better) |
| Revenue growth, 5Y average | −25.1% | – |
| Profitability | ||
| Gross margin | −98.0% | −68.8% (better) |
| Operating margin | −2020% | −696% (better) |
| Net margin | −2449% | −584% (better) |
| FCF margin | – | −473% |
| Return on equity | −968% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −307.0× |
| Current ratio | 0.82 (better) | 0.28 |
| Altman Z-score | −20.40 (better) | −99.19 |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 2.3% | 10.2% |
| Held by insiders | 0.00% | 6.9% |
| Insider net buying, 12 months | – | $4.1M |
| Short interest, % of float | 12.1% | – |
Go deeper
- ISPC stock overview
- ISPC income statement
- ISPC valuation and score
- ONMD stock overview
- ONMD income statement
- ONMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.